Whereas pancreatic cancer will kill an estimated 47,050 people in the United States in 2020; Whereas pancreatic cancer is the third leading cause of cancer-related death in the United States; Whereas, in 2020, pancreatic cancer has killed two American icons—Congressman John Lewis and Supreme Court Justice Ruth Bader Ginsburg; Whereas an additional 57,600 individuals in the United States will be diagnosed with pancreatic cancer in 2020; Whereas of those diagnosed with pancreatic cancer, 66 percent will die within the first year of their diagnosis; Whereas persistent health care inequities and disparities for communities of color compound the devastation of pancreatic cancer; Whereas the incidence rate for pancreatic cancer among Black Americans is 20 percent higher than that of any other racial demographic; Whereas the pancreatic cancer death rate is 17 percent higher for Black men than for White men; Whereas the lack of pancreatic cancer early detection research accelerates the racial unfairness in the United States health care system, with devastating consequences for minorities; Whereas pancreatic cancer has no early detection test to diagnose this cancer quickly and accurately determine the presence of this cancer; Whereas, if diagnosed early, the 5-year survival rate for pancreatic cancer patients is above 80 percent; Whereas if pancreatic cancer is detected late, the 5-year survival rate drops to less than 10 percent; Whereas without adequate funding and early detection research, pancreatic cancer is not discovered until the late stages of this horrific cancer where treatment options are limited; Whereas in fiscal year 2020, pancreatic cancer received its own dedicated research program at the Department of Defense under the Congressionally Directed Medical Research Programs